New drugs.
Waters
L
L
Department of HIV Medicine, St Stephen's Centre, Chelsea and Westminster Hospital, London, UK.
Nelson
M R
MR
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D001577:Benzophenones / Q000627:therapeutic use; D003570:Cytidine Triphosphate / Q000031:analogs & derivatives / Q000627:therapeutic use; D000069454:Darunavir; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000068679:Emtricitabine / Q000031:analogs & derivatives; D006678:HIV / Q000187:drug effects / Q000276:immunology; D023581:HIV Fusion Inhibitors / Q000627:therapeutic use; D054303:HIV Reverse Transcriptase / Q000037:antagonists & inhibitors; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D009570:Nitriles; D011480:Protease Inhibitors / Q000627:therapeutic use; D011724:Pyridazines / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D011743:Pyrimidines; D011753:Pyrones / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D013457:Sulfur Compounds; D016047:Zalcitabine / Q000031:analogs & derivatives / Q000627:therapeutic use
D019380:Anti-HIV Agents; D001577:Benzophenones; D023581:HIV Fusion Inhibitors; D007093:Imidazoles; D009570:Nitriles; D011480:Protease Inhibitors; D011724:Pyridazines; D011725:Pyridines; D011743:Pyrimidines; D011753:Pyrones; D018894:Reverse Transcriptase Inhibitors; D013449:Sulfonamides; D013457:Sulfur Compounds; C451734:etravirine; D003841:Deoxycytidine; D003570:Cytidine Triphosphate; D016047:Zalcitabine; C047723:benzophenone; D054303:HIV Reverse Transcriptase; D000068679:Emtricitabine; C508042:apricitabine; C099405:dexelvucitabine; C075889:Racivir; C433874:capravirine; D000069454:Darunavir; C107201:tipranavir